Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 64, Number 8, April 26, 2005
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richez, C.
Right arrow Articles by Dehais, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richez, C.
Right arrow Articles by Dehais, J.
Related Collections
Right arrowRelated Article
NEUROLOGY 2005;64:1468-1470
© 2005 American Academy of Neurology
Brief Communications

Neuropathy resembling CIDP in patients receiving tumor necrosis factor-{alpha} blockers

C. Richez, MD, P. Blanco, MD, A. Lagueny, MD, T. Schaeverbeke, MD, PhD and J. Dehais, MD

From the Service de Rhumatologie (Drs. Richez, Schaeverbeke, and Dehais) and Service d’Immunologie (Dr. Blanco), Groupe Hospitalier Pellegrin, CHU de Bordeaux, Bordeaux, and Service de Neurologie (Dr. Lagueny), Hopital Haut-Leveque, CHU de Bordeaux, Pessac, and Université Bordeaux 2 (Drs. Richez, Blanco, Lagueny, Schaeverbeke, and Dehais), Bordeaux, France.

Address correspondence and reprint requests to Dr. C. Richez, Service de Rhumatologie, Hôpital Pellegrin, Place Amélie Raba Léon, 33076 Bordeaux Cedex, France; e-mail: christophe.richez{at}club-internet.fr

Tumor necrosis factor-{alpha} (TNF{alpha}) blockers are effective in the treatment of inflammatory arthritis but can induce autoimmune disorders including multiple sclerosis. Described are two patients who developed chronic inflammatory demyelinating polyneuropathy after initiation of anti-TNF{alpha} treatment.

Funded by: Société Française de Rhumatologie.

Received October 27, 2004. Accepted in final form December 30, 2004.


Related Article

April 26 Highlights
Neurology 2005 64: 1326-1327. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 JWatch NeurologyHome page
Do TNF{alpha} Blockers Cause Demyelinating Polyneuropathies?
Journal Watch Neurology, July 7, 2005; 2005(707): 2 - 2.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.